Key points are not available for this paper at this time.
Ginsenoside Rg3 (GS‑Rg3), a sterol molecule isolated from ginseng, has demonstrated various immunological properties, including inhibition of cancer cell proliferation and metastasis, reversal of drug resistance and enhancement of chemotherapy sensitivity. The recent surge in attention towards GS‑Rg3 can be attributed to its potential as an antitumor angiogenesis agent and as a therapeutic candidate for immunotherapy. The development of GS‑Rg3 as an agent for these purposes has accelerated research on its mechanisms of action. The present review summarizes recent studies investigating the antitumor activity of GS‑Rg3 and its underlying mechanisms, as well as providing essential information for future studies on GS‑Rg3.
Liu et al. (Wed,) studied this question.